Cargando…

Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial

BACKGROUND: The Prostate Cancer Prevention Trial has shown a protective effect of finasteride on prostate cancer in low-risk men. It is uncertain whether similar results can be expected when finasteride is used to treat benign prostatic hyperplasia. METHODS: We performed an observational cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murtola, T J, Tammela, T L J, Määttänen, L, Ala-opas, M, Stenman, U H, Auvinen, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736846/ https://www.ncbi.nlm.nih.gov/pubmed/19654575 http://dx.doi.org/10.1038/sj.bjc.6605188

Ejemplares similares

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial
por: Veitonmäki, T, et al.
Publicado: (2014)

False-positive screening results in the Finnish prostate cancer screening trial
por: Kilpeläinen, T P, et al.
Publicado: (2010)

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
por: Määttänen, L, et al.
Publicado: (2007)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kinnunen, Pete T. T., et al.
Publicado: (2017)

European randomized study of prostate cancer screening: first-year results of the Finnish trial
por: Määttänen, L, et al.
Publicado: (1999)

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kaapu, Kalle J, et al.
Publicado: (2016)

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men
por: Siltari, Aino, et al.
Publicado: (2020)

Anti-epileptic drugs and prostate cancer-specific mortality compared to non-users of anti-epileptic drugs in the Finnish Randomized Study of Screening for Prostate Cancer
por: Salminen, Jukka K., et al.
Publicado: (2022)

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial
por: Veitonmäki, Thea, et al.
Publicado: (2016)

Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
por: Murtola, Teemu J., et al.
Publicado: (2018)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

Outcomes of prostate cancer screening among men using antidiabetic medication
por: Vettenranta, A., et al.
Publicado: (2021)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study
por: Peltomaa, A. I., et al.
Publicado: (2021)

Statin use and outcomes of oncological treatment for castration-resistant prostate cancer
por: Peltomaa, A. I., et al.
Publicado: (2023)

Angiosarcoma after radiotherapy: a cohort study of 332 163 Finnish cancer patients
por: Virtanen, A, et al.
Publicado: (2007)

Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men
por: Kaapu, Kalle J., et al.
Publicado: (2018)

Grade-dependent Response to Finasteride in Early Prostate Cancer
por: Rick, Ferenc G., et al.
Publicado: (2016)

Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.
por: Auvinen, A., et al.
Publicado: (1996)

Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
por: Chau, Cindy H., et al.
Publicado: (2015)

Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994.
por: Aho, M, et al.
Publicado: (2000)

Finasteride-Its Impact on Sexual Function and Prostate Cancer
por: Anitha, B, et al.
Publicado: (2009)

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families
por: Fischer, Daniel, et al.
Publicado: (2015)

Pharmacoepidemiological Evaluation in Prostate Cancer—Common Pitfalls and How to Avoid Them
por: Siltari, Aino, et al.
Publicado: (2021)

PALB2 variants in hereditary and unselected Finnish Prostate cancer cases
por: Pakkanen, Sanna, et al.
Publicado: (2009)

Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976–2009
por: Parvinen, I, et al.
Publicado: (2015)

Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States
por: DerSarkissian, Maral, et al.
Publicado: (2016)

A prospective study of lifetime physical activity and prostate cancer incidence and mortality
por: Orsini, N, et al.
Publicado: (2009)

Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine
por: Patasius, Ausvydas, et al.
Publicado: (2019)

Impact of cause of death adjudication on the results of the European prostate cancer screening trial
por: Walter, Stephen D, et al.
Publicado: (2017)

Association of finasteride with prostate cancer: A systematic review and meta-analysis
por: Wang, Lei, et al.
Publicado: (2020)

Cancer incidence among Finnish ferrochromium and stainless steel production workers in 1967–2011: a cohort study
por: Huvinen, Markku, et al.
Publicado: (2013)

Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha‐tocopherol, beta‐carotene cancer prevention (ATBC) study
por: Mondul, Alison M., et al.
Publicado: (2015)

Incidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testing
por: Pashayan, N, et al.
Publicado: (2006)

Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study
por: Julin, B, et al.
Publicado: (2012)

Trends in prostate cancer incidence and mortality in Croatia, 1988 to 2008
por: Kuliš, Tomislav, et al.
Publicado: (2012)

Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease
por: Sipeky, Csilla, et al.
Publicado: (2021)

Diagnostic radiation procedures and risk of prostate cancer
por: Myles, P, et al.
Publicado: (2008)

Do preserved foods increase prostate cancer risk?
por: Jian, L, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_pg1ol65ghc15q1a28eav9el26o